Most side effects are mild and improve within 2-4 weeks as your body adjusts
In fact, the cardiovascular protection of these drugs seems to depend on direct and indirect mechanisms at least partially independent of their hypoglycemic and anorectic action, of variable entity and in some cases modest [56]
In many research discussions, GHK-Cu vs BPC-157 comes down to whether the target is more superficial and collagen-driven, or more structural and musculoskeletal
Remember that most people taking GLP-1 medications experience no vision problems , particularly when appropriate monitoring and gradual glycaemic improvement are implemented
In SURPASS-2, Tirzepatide was compared directly with once-weekly Semaglutide and demonstrated greater HbA1c reduction and greater weight reduction across the studied dose arms
Another way to approach this outcome would be to identify agonists that act on the GLP-1 receptor to produce the same pharmacological outcome